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We report the case of a patient with a case of cytomegalovirus (CMV) colitis,
which presented as a flare-up ofherulcerative colitis. Standard treatment for the
flare-up, which included intravenous corticosteroids, bowel rest, topical salicy-
lates and ultimately colectomy were not effective. The patient did not improve
until therapy with intravenous ganciclovir was initiated.
There have been 26 previous reports ofCMV colitis complicating inflammato-
ry bowel disease (IBD). The diagnosis is not frequently entertained and, if not
made, leads to a high rate ofcolectomy (67 percent) and mortality (33 percent).
Appropriate antiviral therapy appears to eliminate these complications, thus a
high index of suspicion for CMV superinfection in cases of IBD refractory to
traditional therapy is warranted.
INTRODUCTION
Cytomegalovirus (CMV)C is a herpes virus that is quite prevalent in normal adults,
infecting over40 percent ofthe population. Itis usually responsible for active disease only
in immunodeficient patients, although it rarely can cause overt disease in apparently nor-
mal hosts. In the gastrointestinal tract, CMV disease may occur from the mouth to the rec-
tum and is generally manifested by mucosal ulceration often associated with bleeding [1].
In this report we present a patient with ulcerative colitis who presented with refrac-
tory bloody diarrhea and weight loss that did not respond to standard medical manage-
ment. A colectomy was performed, and pathologic examination revealed CMV colitis.
The patient ultimately improved only after treatment with ganciclovir.
To date, there have been 26 reported patients with CMV colitis complicating inflam-
matory bowel disease (IBD). Most were not diagnosed prior to undergoing colectomy.
Although unusual, it is important to consider CMV in patients with IBD flare-ups refrac-
tory to conventional therapy, as appropriate anti-viral therapy may spare the patient non-
elective surgery.
CASE REPORT
J.C. is a 56-year-old white female who was in good health until 1992 when she pre-
sented to a gastroenterologist with a three-month history of diarrhea. She had no family
history ofimmune disorders and no past history ofherpes infections. A work-up revealed
brown, heme-positive stool, and flexible sigmoidoscopy showed a normal rectum, with
moderate to severe colitis of the sigmoid and left colon, which was felt to be consistent
a To whom all correspondence should beaddressed: Dennis G. Begos, M.D., Department of Colon
and Rectal Surgery, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.
Phone: (216) 444-2200; Fax: (216) 444-1162.
cAbbreviations: CMV, cytomegalovirus; IBD, inflammatory bowel disease; 6-MP, 6-mercaptop-
urine.
323Begos et al.: CMVinfection in ulcerative colitis
with Crohn's colitis. She was treated briefly with intravenous corticosteroids, followed by
oral steroids for several weeks and was maintained on olsalazine. Three months following
this initial presentation, she had a flare-up that was effectively treated with a briefcourse
ofIV corticosteroids, and she was discharged on mesalamine by mouth, and by enema, as
well as 6-mercaptopurine (6-MP). The 6-MP was discontinued because ofleukopenia sev-
eral months later. She did well on mesalamine forthe nextseveral years, notrequiringhos-
pitalization or steroid treatment until July of 1995.
In July of 1995, she was admitted with a three-month history of bloody diarrhea
uncontrolled with ciprofloxacin or metronidazole (which had been added to her
mesalamine), a 15 pound weight loss and epigastric pain radiating to her back. She had a
mild increase in her amylase and lipase and was treated with total parenteral nutrition, IV
steroids and mesalamine enemas. Colonoscopy on hospital day two revealed severe colitis
ofthe distal 50 centimeters ofcolon, consistent with ulcerative colitis. Her serum amylase
and lipase values rapidly returned to normal, but her diarrhea persisted despite continued
IV steroids, 6-MP and antibiotics. Stool cultures for ova, parasites andE. coli wererepeat-
edly negative, as were titers of C. dificile toxin. Because ofher blood loss perrectum, she
required several transfusions ofpacked red blood cells. She developed oral lesions and o-
dynophagiaapproximately 10days into herhospital course, which werethoughtto becon-
sistent with candida pharyngitis. Shortly after this, her white blood cell count began to
drop, from a high of 15,000 cells/mm3 to a nadir of 1,300 cells/mm3 over the course of
seven days. 6-MP was discontinued, buther leukopeniadid not improve. She was brought
to the operating room three weeks into herhospitalization and underwent an extended left
hemicolectomy with colostomy and Hartmann's pouch. Pathologic examination revealed
CMV colitis (Figure 1). She was tested for antibodies to the human immuno-deficiency
virus (HIV), which were absent. Treatment with intravenous ganciclovir was initiated at a
Figure 1. a. (left): Photmicrograph of the colon showing intense mucosal inflammation. b.
(right): Higher power photomicrograph of colonic mucosa showing intense lymphocytic
inflammation and a cytomegalic cell in the center ofthe field.
324Begos et al.: CMVinfection in ulcerative colitis
dose of 10 mg/kg/day in two divided doses. After two days, her leukopenia improved, and
after four days she had a normal white blood cell count. Likewise, her diarrhea, which had
persisted, improved over the same period. She required no further transfusions and began
tolerating a regular diet. She was discharged from the hospital after four weeks of intra-
venous ganciclovir therapy, to complete an additional two weeks ofIV therapy at home.
DISCUSSION
Cytomegalovirus infection is quite common in normal adults and is generally asymp-
tomatic, with the virus remaining latent in white blood cells for the life of the host [1].
Clinically significant disease occurs in patients with defective cell-mediated immunity,
especially transplant patients, AIDS patients and those receiving chemotherapy. Disease
is usually a result of reactivation of latent virus, rather than re-infection, thus measuring
levels ofCMV antibody is often not helpful in establishing a diagnosis. Significant CMV
disease may be manifested in a variety of organs, including the retina, the lung and the
gastrointestinal tract, and the target organ seems to be specific to the etiology of the
immunodeficiency [1].
Gastrointestinal CMV disease may occur from mouth to rectum, with non-specific
gross lesions consisting of erosions, ulcerations and mucosal hemorrhage.
Microscopically, submucosal vasculitis or microvascular thrombosis is often present, as
was the case in our patient. Tissue necrosis may also be a prominent feature. Diagnosis is
made histologically by identifying large cells with intranuclear and intracytoplasmic
inclusions; culture of lesions or biopsy specimens is neither sensitive nor specific [1].
Immunohistochemical staining forCMV antigen, in situ hybridization formRNA, and the
polymerase chain reaction forCMV DNAmay improve sensitivity, although these may be
positive in the latent state.
There have been a total of26 reported cases ofCMV colitis complicating inflamma-
tory bowel disease [2-16]; ourpatient represents the 27th. The vast majority ofcases (24)
have been in patients with ulcerative colitis; one patient [10] had Crohn's ileocolitis, and
one [3] had indeterminate colitis. Although initially diagnosed with Crohn's colitis, our
patient has clinical and pathologic manifestations more consistent with ulcerative colitis.
Fourteen ofthe previously reported cases had theirdiagnosis ofCMV colitis less than
six months after the diagnosis ofinflammatory bowel disease (Figure 2). This raises the
possibility that the patients may nothave had inflammatory bowel disease atall, butin fact
had primary CMV colitis. In at least four patients, however, [4, 13, 15] ulcerative colitis
symptoms persisted after adequate treatment for and resolution of CMV infection. This
leads to a more intriguing speculation, that CMV infection somehow plays a role in the
onset of ulcerative colitis, as proposed by Orvar and colleagues [4]. Other investigators
[17, 18] have also sought for a link between CMV or other viral infections and IBD, but
no study has been able to convincingly demonstrate a causal relationship. It is known, for
example, that CMV infection in tissue culture causes induction of MHC class I surface
antigen expression [19], as well as cytokine production in monocytes [20]. Thus CMV
infection in colonocytes may trigger an autoimmune response in the susceptible host,
which leads to the clinical and pathologic manifestations of ulcerative colitis. Others [3,
4] have suggested, and we concur, that a screening for viral infections be undertaken as
part of the initial work-up in patients presenting with new onset inflammatory bowel dis-
ease. Additionally, it is prudent to have a high index ofsuspicion for CMV superinfection
in apatient who presents with aflare-up ofinflammatory bowel disease thatis notprompt-
ly responsive to standard management.
The clinical sequelae of delayed or missed diagnosis ofCMV colitis may have con-
siderable significance. As reported by Loftus et al., of five patients with primary CMV
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<3 months 3-6 months
>6 months unknown
Figure 2. The duration of inflammatory bowel disease (IBD) prior to diagnosis of
cytomegalovirus (CMV) colitis. The numbers represent patients, with percentages in parentheses.
6(22%)
tj6(13.6%)
1(3.5%)
M3 none <1 month 0 1-3 months
E > 3 months M unknown
Figure 3. The length ofsteroid therapy prior to the diagnosis ofcytomegalovirus (CMV) coli-
tis in 27 patients with inflammatory bowel disease. The numbers represent patients, with per-
centages in parentheses.
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colitis initially diagnosed with inflammatory bowel disease and treated with corticos-
teroids, four died [2]. Of the 27 patients (including ours) with inflammatory bowel dis-
ease and CMV superinfection, 14 required colectomy. Six patients were correctly diag-
nosed on colonoscopic biopsy and treated appropriately with ganciclovir; in none ofthese
patients was colectomy necessary [2, 4, 14-16]. Thus, untreated CMV infection in the set-
ting ofinflammatory bowel disease carries a67 percentcolectomy rate. Patients withdoc-
umented CMV colitis who are on corticosteroids may also respond simply to steroid
withdrawal [3]. All patients who received ganciclovir treatment survived without requir-
ing colectomy, but seven of the 21 patients (33 percent) who did not receive ganciclovir
died, four after undergoing colectomy.
It is commonly stated that a majorpredisposing factor forpatients with IBD in devel-
oping CMV colitis is corticosteroid immunosuppression. Although this is undoubtedly
true in some ofthe case reports, five patients were on no corticosteroid therapy at the time
oftheir diagnosis. Additionally, 16 patients (including ours) had been on steroids for less
than three months and seven for less than one month (Figure 3). Thus, the majority of
patients were notreceiving long-term steroid therapy. Therefore, theremay be some unde-
fined factor that predisposes patients with IBD to develop CMV infection.
Cytomegalovirus has a known propensity to invade rapidly growing tissue [21], such as
granulation tissue in an ulcer bed, which may be present in patients with IBD. This has
led some to conclude that CMV is not pathogenic in these cases [5], but rather an "inno-
centbystander," which does not alter the course ofthe disease. In their series, Eyre-Brook
and Dundas [5] found CMV in three of 12patientsrequiring urgentcolectomy, but in none
of 14 patients undergoing elective resection and concluded that CMV did not alter the
course ofthe ulcerative colitis. However, none ofthe three patients in this report received
appropriate antiviral therapy. It would seem, given the success in avoiding colectomy in
patients with CMV colitis and IBD adequately treated with ganciclovir, that this conclu-
sion is not supported. Cooper and colleagues [11] have identified an association between
CMV, ulcerative colitis and toxic megacolon. Cytomegalovirus inclusion bodies were
identified in five ofseven patients with ulcerative colitis requiring emergentcolectomy for
toxic megacolon [11]. The other reported cases ofCMV in IBD do not include any with
toxic megacolon, however.
In summary, therefore, although CMV infection complicating or initiating inflamma-
tory bowel disease appears to be uncommon, it may be under-diagnosed. Ifmissed, how-
ever, it carries with it a substantial morbidity in terms of emergency colectomy and pro-
longed hospitalization and a mortality of 33 percent. Additionally, the concept that CMV
or other viral infection may play a role in the etiology of inflammatory bowel disease is
an area which merits further investigation.
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